多支或单支动脉搭桥术与经皮冠状动脉介入治疗在三支或左主干病变患者中的比较
该研究为SYNTAX延长生存研究的post hoc分析,比较PCI与使用多支动脉移植(MAG)或单支动脉移植(SAG)的CABG在三支病变(3VD)和/或左主干病变(LMCAD)患者中的长期全因死亡率。中位随访11.9年,MAG较PCI显著降低全因死亡率(调整HR 0.66,95%CI 0.49-0.89),而SAG与PCI无显著差异。在3VD患者中MAG和SAG均优于PCI,但在LMCAD患者中未见显著差异。
要点
- MAG较PCI显著降低长期全因死亡率(调整HR 0.66),SAG与PCI无显著差异。
- 在3VD患者中,MAG和SAG均较PCI显著降低死亡率。
- 在LMCAD患者中,PCI与MAG或SAG之间无显著死亡率差异。
核心结论
- MAG可能是CABG更理想的配置,能在3VD和/或LMCAD患者中比PCI实现更低的长期全因死亡率。
研究设计与样本
- SYNTAX延长生存研究的post hoc分析,比较PCI与CABG(MAG或SAG)在3VD和/或LMCAD患者中的生存,随访≥10年。
- 共纳入1743例患者,其中PCI 901例(51.7%),SAG 532例(30.5%),MAG 310例(17.8%)。
- 主要终点为最大随访(中位11.9年)时的全因死亡率,在as-treated人群中评估。
主要发现
- 最大随访时,PCI、SAG、MAG组全因死亡分别发生305例(33.9%)、175例(32.9%)、70例(22.6%)(P < 0.001)。
- 与PCI相比,MAG与显著较低的全因死亡率相关(调整HR 0.66,95%CI 0.49-0.89),SAG无显著差异(调整HR 0.83,95%CI 0.67-1.03)。
- 在3VD患者中,MAG(调整HR 0.55,95%CI 0.37-0.81)和SAG(调整HR 0.68,95%CI 0.50-0.91)均与显著较低的死亡率相关。
- 在LMCAD患者中,PCI与MAG(调整HR 0.90,95%CI 0.56-1.46)或SAG(调整HR 1.11,95%CI 0.81-1.53)之间无显著差异。
- 在三个主要心肌 Territory 均实现血运重建的患者中,接受动脉移植的心肌 Territory 数量与生存呈正相关(Ptrend = 0.003)。
临床怎么用
- 对于3VD和/或LMCAD患者,CABG时优先考虑MAG以降低长期全因死亡率。
- 在3VD患者中,SAG也可作为优于PCI的选择。
- 在LMCAD患者中,PCI与CABG(MAG或SAG)的长期死亡率无显著差异,决策需个体化。
局限性
- 本研究为post hoc分析,非随机比较MAG与SAG。
- 结果基于as-treated人群,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of this study was to compare long-term all-cause mortality between patients receiving percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) using multiple (MAG) or single arterial grafting (SAG). METHODS AND RESULTS: The current study is a post hoc analysis of the SYNTAX Extended Survival Study, which compared PCI with CABG in patients with three-vessel (3VD) and/or left main coronary artery disease (LMCAD) and evaluated survival with ≥10 years of follow-up. The primary endpoint was all-cause mortality at maximum follow-up (median 11.9 years) assessed in the as-treated population. Of the 1743 patients, 901 (51.7%) underwent PCI, 532 (30.5%) received SAG, and 310 (17.8%) had MAG. At maximum follow-up, all-cause death occurred in 305 (33.9%), 175 (32.9%), and 70 (22.6%) patients in the PCI, SAG, and MAG groups, respectively (P < 0.001). Multiple arterial grafting [adjusted hazard ratio (HR) 0.66, 95% confidence interval (CI) 0.49-0.89], but not SAG (adjusted HR 0.83, 95% CI 0.67-1.03), was associated with significantly lower all-cause mortality compared with PCI. In patients with 3VD, both MAG (adjusted HR 0.55, 95% CI 0.37-0.81) and SAG (adjusted HR 0.68, 95% CI 0.50-0.91) were associated with significantly lower mortality than PCI, whereas in LMCAD patients, no significant differences between PCI and MAG (adjusted HR 0.90, 95% CI 0.56-1.46) or SAG (adjusted HR 1.11, 95% CI 0.81-1.53) were observed. In patients with revascularization of all three major myocardial territories, a positive correlation was observed between the number of myocardial territories receiving arterial grafts and survival (Ptrend = 0.003). CONCLUSION: Our findings suggest that MAG might be the more desirable configuration for CABG to achieve lower long-term all-cause mortality than PCI in patients with 3VD and/or LMCAD. TRIAL REGISTRATION: Registered on clinicaltrial.gov. SYNTAXES: NCT03417050 (https://clinicaltrials.gov/ct2/show/NCT03417050); SYNTAX: NCT00114972 (https://www.clinicaltrials.gov/ct2/show/NCT00114972).
引用
- Davierwala PM, Gao C, Thuijs DJFM, et al. Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease. Eur Heart J. 2022. PMID: 34405875. doi:10.1093/eurheartj/ehab537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。